Holding · 1.2% · hold (from 1.2%) · mega · Technology · last 301.11
Entry 295.00–307.00 · Stop 274.00 · Target 355.00 · Hold (on target)
Long thesis after a record quarter (F-LRCX-1, F-LRCX-2). A small 1.2% position is an acceptable gap risk into the Oct 21 results. Exit on a close below 274.
Thesis (long, position, conviction 55)
Bull: Lam just posted record results: Q4 FY2026 revenue of $6.72B (+15.1% q/q), GAAP operating margin of 37.4%, and diluted EPS of $1.81, with non-GAAP EPS beating consensus by ~6% (F-LRCX-1, F-LRCX-2, F-LRCX-9). CY2025 revenue grew to $23.23B from $18.44B in CY2024, a 26% expansion (F-LRCX-5), and the balance sheet carries $5.6B of cash (F-LRCX-3). Sell-side sentiment is overwhelmingly positive — 35 of 41 tracked analysts rate it buy/strong buy with zero sells (F-LRCX-10). Despite a sharp price pullback, the stock remains well above its 200-day moving average ($280.01 vs. last price $301.11), signaling the longer-term uptrend is intact even as short-term momentum has cooled (F-LRCX-6). RSI at 42.8 is neutral, not overbought, leaving room to run. The ~30% drawdown from 52-week highs and 3-month underperformance versus SPY of 13.5pp (F-LRCX-7, F-LRCX-8) looks more like a sentiment/cyclical air-pocket than a fundamental breakdown, given the record quarter that was just reported.
Bear: The stock is in a clear short-term downtrend, trading below both its 20-day ($314.09) and 50-day ($310.93) moving averages (F-LRCX-6), and has underperformed the market by 13.5 points over three months (F-LRCX-8) — the market is pricing in a risk the headline numbers don't yet show. Taiwan and China together made up 53% of quarterly revenue (27% + 26%) (F-LRCX-4), a concentration that leaves Lam exposed to export-control tightening or China capex digestion, a plausible explanation for the de-rating despite strong fundamentals. There's a near-term binary catalyst: an earnings report expected ~2026-10-21 with consensus calling for EPS of $2.22 and revenue of $8.31B — a big sequential step-up (~24% revenue growth q/q) versus the $6.72B/$1.81 just delivered (F-LRCX-1, F-LRCX-2, catalyst). A miss against that elevated bar, or cautious China-related commentary, could extend the drawdown given the stock is already 30% below its 52-week high (F-LRCX-7) and semicap sentiment can swing hard on single data points.
Valuation: The brief lacks a current P/E, FCF yield, or forward multiple, so this isn't a precise valuation call — but on reported fundamentals (37.4% GAAP operating margin, 26% YoY CY2025 revenue growth, EPS compounding alongside the revenue ramp) the business quality is high and improving. A 30% pullback from highs alongside record (not deteriorating) results suggests price has moved ahead of fundamentals on the downside, i.e., the multiple has compressed even as earnings power grew, which is constructive for entry — though without hard multiple data this is directional, not precise.
Catalysts
2026-10-21: Q1 FY2027 earnings report; consensus EPS $2.2199 and revenue ~$8.31B versus last quarter's $6.72B/$1.81 actual — a meaningful beat/miss swing factor
undated: Commentary on China/Taiwan export-control exposure given 53% combined revenue concentration
Facts
F-LRCX-1: For the quarter ended June 28, 2026, Lam reported revenue of $6.722 billion, up 15.1% from the previous quarter. (as of 2026-07-29)[E5554]source
F-LRCX-2: For the quarter ended June 28, 2026, GAAP operating margin was 37.4% and diluted EPS was $1.81. (as of 2026-07-29)[E5554]source
F-LRCX-3: Cash, cash equivalents and restricted cash totaled $5.60 billion at the end of the quarter ended June 28, 2026. (as of 2026-06-28)[E5554]source
F-LRCX-4: Taiwan and China accounted for 27% and 26%, respectively, of revenue in the quarter ended June 28, 2026. (as of 2026-06-28)[E5554]source
F-LRCX-5: Lam's CY2025 revenue was $23.23 billion, compared with $18.44 billion for CY2024. (as of 2025-12-31)[E5553]
F-LRCX-6: LRCX closed at $301.11 on October 13, 2026, below its 20-day moving average of $314.09 and 50-day average of $310.93, but above its 200-day average of $280.01. (as of 2026-10-13)[E5288]
F-LRCX-7: As of October 13, 2026, LRCX was 30.44% below its 52-week closing high and had a 3-month return of -10.14%. (as of 2026-10-13)[E5288]
F-LRCX-8: Over the three months ended October 13, 2026, LRCX underperformed SPY by 13.47 percentage points. (as of 2026-10-13)[E5288]
F-LRCX-9: Lam's Q4 FY2026 non-GAAP diluted EPS of $1.82 exceeded the $1.7172 estimate by 5.99%. (as of 2026-07-29)[E5311, E5554]source
F-LRCX-10: For September 2026, analyst recommendations tracked by Finnhub included 10 strong buys, 25 buys, 6 holds, and no sells or strong sells. (as of 2026-09-01)[E5311]
What would change the view
A post-earnings close below 280 (the 200-day MA) on heavy volume
China/Taiwan revenue concentration rises above current 53% combined with explicit new export restrictions announced
Q1 FY2027 results show GAAP operating margin falling below ~33% (a meaningful step down from 37.4%)
Analyst consensus flips to net downgrades following the Oct 21 print
Data quality
Quality score 96/100.
Gap: The quote block is timestamped October 14, 2026, after the context date of October 13, so the October 13 daily close is used instead.
Gap: The quarterly fundamentals fallback omits some quarter observations; quarterly results cited here come from Lam's SEC-filed earnings release.